These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 8998787

  • 21. Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
    Goldschmidt M, Landzberg BR, Frishman WH.
    J Clin Pharmacol; 1996 Jul; 36(7):559-72. PubMed ID: 8844437
    [Abstract] [Full Text] [Related]

  • 22. Acute haemodynamic effects of nicorandil in patients with chronic severe regurgitant valvular lesions.
    Yadav R, Bhargava B, Aggarwal R, Narang R, Chopra A, Sapra R, Manchanda SC.
    Indian Heart J; 1998 Jul; 50(2):173-8. PubMed ID: 9622984
    [Abstract] [Full Text] [Related]

  • 23. An ATP-sensitive potassium (KATP) channel opener, nicorandil, lowers the threshold for ischemic preconditioning in barbital-anesthetized dogs.
    Mizumura T, Saito S, Ozawa Y, Kanmatsuse K, Gross GJ.
    Heart Vessels; 1997 Jul; Suppl 12():175-7. PubMed ID: 9476575
    [Abstract] [Full Text] [Related]

  • 24. [Nicorandil, a potassium channel agonist].
    Gerson C.
    Soins; 1996 Nov; (610):61. PubMed ID: 9016185
    [No Abstract] [Full Text] [Related]

  • 25. Effects of nicorandil preconditioning on membrane dystrophin.
    Shojima T, Hayashida N, Nishi A, Takagi K, Hori H, Yoshikawa K, Aoyagi S.
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):472-9. PubMed ID: 16859916
    [Abstract] [Full Text] [Related]

  • 26. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction.
    Sakata Y, Kodama K, Ishikura F, Komamura K, Hasegawa S, Sakata Y, Hirayama A.
    Jpn Circ J; 1997 May; 61(5):455-8. PubMed ID: 9192246
    [Abstract] [Full Text] [Related]

  • 27. Evolving Issues in the Treatment of Ischaemic Heart Disease: The Potassium Channel Openers. Symposium proceedings. Barcelona, Spain, 2 September 1992.
    Eur Heart J; 1993 Jul; 14 Suppl B():1-52. PubMed ID: 8103740
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Effects of nicorandil on regional cerebral oxygen saturation].
    Kasuya Y, Dohi S.
    Masui; 1997 Oct; 46(10):1305-9. PubMed ID: 9369043
    [Abstract] [Full Text] [Related]

  • 36. [Studies on the relation between collateral development and the effects of antianginal drugs--effects of nitroglycerin and 2-nicotinamidethyl nitrate on collateral circulation (author's transl)].
    Inou T.
    Fukuoka Igaku Zasshi; 1981 Aug; 72(8):440-67. PubMed ID: 6457779
    [No Abstract] [Full Text] [Related]

  • 37. Coronary hemodynamics in heart failure and effects of therapeutic interventions.
    Chatterjee K.
    J Card Fail; 2009 Mar; 15(2):116-23. PubMed ID: 19254670
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.